Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study
Clinical trial NCT04190745 · UNKNOWN
Trial details
- NCT number
- NCT04190745
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-29
- Primary completion
- 2023-09-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.